Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A computer-aided simulation approach in the development of a prolonged release formulation.

S Rossi1, F Ferrari, M C Bonferoni

  • 1Dipartimento di Chimica Farmaceutica, Università di Pavia.

Bollettino Chimico Farmaceutico
|December 1, 1991
PubMed
Summary

This study validates computer simulations for predicting diltiazem plasma levels from prolonged-release formulations. The in vitro-in vivo correlation approach ensures accurate forecasting for drug development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Impact of Dual Cannabis and Tobacco Smoking in Young Patients With Lung Cancer: Results From the Prospective "Environment and Lung Cancer" Study.

Chest·2025
Same author

Induction immunotherapy plus chemotherapy for Pancoast lung cancer tumors: are we ready to shift our standards?

ESMO open·2025
Same author

Effect of troxerutin in counteracting hyperglycemia-induced VEGF upregulation in endothelial cells: a new option to target early stages of diabetic retinopathy?

Frontiers in pharmacology·2022
Same author

Role of the cytopathologist during the procedure of fine-needle aspiration biopsy of thyroid nodules.

Insights into imaging·2021
Same author

Artificial intelligence solution to classify pulmonary nodules on CT.

Diagnostic and interventional imaging·2020
Same author

Radiofrequency ablation versus surgical resection for the treatment of oligometastatic lung disease.

Diagnostic and interventional imaging·2020

Area of Science:

  • Pharmacology
  • Pharmaceutical Technology
  • Drug Delivery Systems

Background:

  • Diltiazem is effective for coronary insufficiency and arterial hypertension.
  • Extended-release diltiazem formulations utilize various retardation mechanisms.
  • Optimizing drug release profiles is crucial for therapeutic efficacy.

Purpose of the Study:

  • To evaluate two prolonged-release oral diltiazem formulations (once-daily and twice-daily).
  • To validate an in vitro release test using an in vitro-in vivo correlation (IVIVC).
  • To assess the predictive accuracy of computer simulations for plasma drug levels.

Main Methods:

  • In vitro drug release testing of two diltiazem formulations.
  • Validation of the in vitro release method using an IVIVC approach.

Related Experiment Videos

  • In silico simulation of plasma drug concentration profiles using previously developed software.
  • In vivo pharmacokinetic studies to measure actual plasma drug levels after single dosing.
  • Comparison of simulated versus measured plasma levels.

    • Main Results:

    • The in vitro release test was successfully validated.
    • Computer simulations accurately predicted plasma drug levels for both formulations.
    • A good agreement was observed between measured and simulated diltiazem plasma profiles.
    • The predictive utility of the simulation approach was confirmed.

    Conclusions:

    • The validated in vitro release test and simulation approach are useful tools in pharmaceutical formulation development.
    • This method aids in predicting in vivo performance of extended-release diltiazem formulations.
    • The study demonstrates the reliability of in silico methods for guiding drug product design.